BTI
CTXR icon

Blue Trust Inc’s Citius Pharmaceuticals CTXR Stock Holding History

Blue Trust Inc’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-120
Closed -$1.75K – 2555
2024
Q3 		$1.75K Hold
120
– – ﹤0.01% 2605
2024
Q2 		$2.69K Hold
120
– – ﹤0.01% 2373
2024
Q1 		$2.69K Hold
120
– – ﹤0.01% 1763
2023
Q4 		$2K Hold
120
– – ﹤0.01% 2119
2023
Q3 		$4K Hold
120
– – ﹤0.01% 1685
2023
Q2 		$4K Buy
+120
New +$3.95K ﹤0.01% 1576

Other funds holding CTXR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return

Blue Trust Inc's CTXR Position: Q4 2024 in Review

Blue Trust Inc sold out of Citius Pharmaceuticals (CTXR) in Q4 2024, closing a stake of 120 shares — an estimated $1.75K sold.

Blue Trust Inc first reported a position in CTXR in Q2 2023 and held it in 6 quarters. The position peaked at $4K in Q3 2023. 30 funds tracked by Wall St. Rank hold CTXR as of Q4 2024.

  • Blue Trust Inc reported no remaining Citius Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Blue Trust Inc sold 120 Citius Pharmaceuticals shares in Q4 2024, an estimated $1.75K.
  • Blue Trust Inc first reported a position in Citius Pharmaceuticals in Q2 2023 and held it in 6 quarters.
  • Blue Trust Inc's Citius Pharmaceuticals position peaked at $4K in Q3 2023.
  • 30 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.